11:57 AM EST - Abattis Bioceuticals Corp. : Announced Tuesday that, further to its news release dated December 15, 2017, it has completed the first tranche of its non-brokered private placement of units for gross proceeds of up to $6 million. The Company intends to use the proceeds from the Private Placement to pursue strategic assets, expand its laboratory business, expand its extraction technology business and for working capital and general corporate purposes. Abattis Bioceuticals Corp.
shares ATT:CNX are trading down 4.5 cents at $0.50.
